Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor

Abstract:

Heparin binds antithrombin and increases more than thousand times the rate of the anticoagulant activity. Another activity of heparin is the inhibition of the human complement system. The results from several laboratories have shown that both biological activities of heparin are independent. The main aim of this work was to study how heparin and antithrombin recognize each other. First experiments were done with the system heparin and Concanavalin A. The lectin recognizes and precipitates the fraction of the heparin molecule with high affinity for antithrombin, and high anticoagulant activity. Low ionic strength and the presence of calcium ions are absolute requirements for the recognition. When, instead of Con A, the first component of the complement system was used for the interaction, and under similar and very specific conditions, again precipitate the fraction of heparin with high affinity for antithrombin and high anticoagulant activity. The conclusion is that both heparin biological activities reside in the same limited fraction of the molecule which containes the segment with high affinity for antitrombin. These results are in opposition with most reported in the literature, but we have demonstrated that specific interactions between macromolecules only detect it under very low ionic strength, and in the presence of calcium ions.

Registro:

Documento: Artículo
Título:The active fraction of heparin enclose both properties: Anticoagulant and anticomplement
Autor:Recondo, E.F.; Calabrese, G.; Fernández, M.E.
Filiación:Depto. de Quím. Biol., Fac. de Ciencias Exactas y Naturales, Ciudad Universitaria, Nunez, (1428), Buenos Aires, Argentina
Depto. de Ciencias Biológicas, Fac. de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 954, (1110), Buenos Aires, Argentina
Palabras clave:Calcium ions; First component of the complement system; Heparin; Low ionic strength; Molecular interactions; anticoagulant agent; calcium ion; complement inhibitor; concanavalin A; heparin; anticoagulation; article; complement inhibition; complement system; controlled study; human; ionic strength; molecular interaction; precipitation
Año:2003
Volumen:37
Número:2
Página de inicio:193
Página de fin:201
Título revista:Acta Bioquimica Clinica Latinoamericana
Título revista abreviado:Acta Bioquim. Clin. Latinoam.
ISSN:03252957
CODEN:ABCLD
CAS:calcium ion, 14127-61-8; concanavalin A, 11028-71-0; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03252957_v37_n2_p193_Recondo

Referencias:

  • Lam, L.H., Silbert, J.E., Rosenberg, R.D., The separation of active and inactive forms of heparin (1976) Biochem Biophys Res Commun, 69 (2), pp. 570-577
  • Hopwood, J., Hook, M., Linker, A., Lindahl, U., Anticoagulant activity of heparin: Isolation of antithrombin-binding sites (1976) FEBS Lett, 69 (1), pp. 51-54
  • Abildgaard, U., (1979) The Physiological Inhibitors of Blood Coagulation and Fibrinolysis, pp. 31-33. , Collen D, Wiman B, Verstraete M eds, North-Holland, Amsterdam: Elsevier
  • Rosenberg, R.D., Armand, G., Lam, L., Structure-function relationships of heparin species (1978) Proc Natl Acad Sci USA, 75 (7), pp. 3065-3069
  • Lindahl, U., Backstrom, G., Hook, M., Thunberg, L., Fransson, L.A., Linker, A., Structure of the antithrombin-binding site in heparin (1979) Proc Natl Acad Sci USA, 76 (7), pp. 3198-3202
  • Thunberg, G., Backstrom, G., Grundberg, H., Riesenfeld, J., Lindahl, U., (1980) FEBS Lett, 117 (1), pp. 203-206
  • Oosta, G.M., Gardner, W.T., Beeler, D.L., Rosenberg, R.D., Multiple functional domains of the heparin molecule (1981) Proc Natl Acad Sci USA, 78 (2), pp. 829-833
  • Doyle, R.J., Kahn, T.J., Interaction between Concanavalin A and heparin (1972) Febs Let, 20 (1), pp. 22-24
  • Kalb, A.J., Levitzki, A., Metal-binding sites of Concanavalin A and their role in the binding of α-methyl D-glucopyranoside (1968) Biochem J, 109, pp. 669-672
  • Becker, J.W., Reeke G.N., Jr., Cunningham, B.A., Edelman, G.M., New evidence on the location of the saccharide-binding site of Concanavalin A (1976) Nature, 259, pp. 406-409
  • Brewer, C.F., Brown R.D. III, Koenig, S.H., Stoichiometry of manganese and calcium ion binding to Concanavalin A (1983) Biochemistry, 22, pp. 3691-3702
  • Fernández De Recondo, M.E., Legorburu, C., Monge, J.C., Recondo, E.F., Heparin and Concanavalin A interaction: Isolation of a fraction with higher anticoagulant activity (1988) Biochem Biophys Res Commun, 155 (1), pp. 216-223
  • Monge, J.C., Recondo, E.F., Fernández De Recondo, M.E., Heparin and Concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity (1989) Thrombosis Res, 54, pp. 237-243
  • Monge, J.C., Legorburu, C., Fernández De Recondo, M.E., Recondo, E.F., Heparin and Concanavalin interaction: A useful model for study the mechanism of anticoagulant activity (1989) Ann New York Acad Sc, 556, pp. 462-464
  • Fernández De Recondo, M.E., Monge, J.C., Recondo, E.F., Interaction of Concanavalin A with a fraction of dermatan sulfate containing a very high anticoagulant activity (1995) Cell Mol Biol, 41 (4), pp. 465-472
  • Edens, R.E., Lindhart, R.J., Weiler, J.M., Heparin is not just an anticoagulant anymore: Six and one half decades of studies on the ability of heparin to regulate complement activity 1993: Complement Today. Complement Profiles, 1, pp. 96-120. , Cruse JM, Lewis RE Jr. (Eds). Basel, Karger
  • Almeda, S., Rosenberg, R.D., Bing, D.H., The binding properties of human complement component C1q; interaction with mucopolysaccharides (1983) J Biol Chem, 258, pp. 785-791
  • Casu, B., Structure and biological activity of heparin (1985) Adv Carbohydr Chem Biochem, 43, pp. 51-134
  • Maillet, F., Petitou, M., Choay, J., Kazatchkine, M.D., Structure-function relationship in the inhibitory effect of heparin on complement activation: Independency of anticoagulant and anti-complementary sites on heparin molecule (1988) Mol Immunol, 25, pp. 917-923
  • Hennick, W.E., Klerx, J.P.A.M., Van Dijk, H., Feijen, J., Complement inhibitory and anticoagulant activities of fractioned heparins (1984) Thromb Res, 36, pp. 281-292
  • Calabrese, G.C., Recondo, M.M., Fernández De Recondo, M.E., Recondo, E.F., The first component of the human complement system recognizes the active fraction of heparin (1997) Cell and Mol Biol, 43 (2), pp. 237-242
  • Calabrese, G.C., Leocata Nieto, F., Recondo, E.F., Fernández De Recondo, M.E., An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system (2001) Cel and Mol Biol, 47 (17), pp. 127-131
  • Calabrese, G.C., Recondo, E.F., Fernández De Recondo, M.E., Antithrombin and first protein C1 recognize the same active heparin fraction (2002) Thromb Res, 105, pp. 537-541
  • Bing, D., Purification of the first component of human complement by affinity chromatography on human g Globulin linked to sepharose (1971) J Immunol, 107 (5), pp. 1243-1249
  • Tenner, A.J., Lesavre, P.H., Cooper, N.R., Purification and radiolabeling of human C1q (1981) J Immunol, 127 (2), pp. 648-653
  • Bing, D., Nature of the active site of a subunit of the first component of human complement (1969) Biochem, 8 (11), pp. 4503-4509
  • Rodríguez Montelongo, L., Fernández De Recondo, M.E., Recondo, E.F., Un nuevo método químico para la determinación de heparina y otros glicosaminoglicanos naturales (1986) Acta Bioquím Clín Latinoam, 20 (3), pp. 433-437
  • (1999) Farmacopea Británica A176 Appendix XIV D. Biological Assay of Heparin

Citas:

---------- APA ----------
Recondo, E.F., Calabrese, G. & Fernández, M.E. (2003) . The active fraction of heparin enclose both properties: Anticoagulant and anticomplement . Acta Bioquimica Clinica Latinoamericana, 37(2), 193-201.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03252957_v37_n2_p193_Recondo [ ]
---------- CHICAGO ----------
Recondo, E.F., Calabrese, G., Fernández, M.E. "The active fraction of heparin enclose both properties: Anticoagulant and anticomplement " . Acta Bioquimica Clinica Latinoamericana 37, no. 2 (2003) : 193-201.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03252957_v37_n2_p193_Recondo [ ]
---------- MLA ----------
Recondo, E.F., Calabrese, G., Fernández, M.E. "The active fraction of heparin enclose both properties: Anticoagulant and anticomplement " . Acta Bioquimica Clinica Latinoamericana, vol. 37, no. 2, 2003, pp. 193-201.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03252957_v37_n2_p193_Recondo [ ]
---------- VANCOUVER ----------
Recondo, E.F., Calabrese, G., Fernández, M.E. The active fraction of heparin enclose both properties: Anticoagulant and anticomplement . Acta Bioquim. Clin. Latinoam. 2003;37(2):193-201.
Available from: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03252957_v37_n2_p193_Recondo [ ]